Patients with tinnitus. Tinnitus
Conditions
Interventions
Intervention 1: Intervention group: The drug group received 250 mg sodium valproate tablets orally twice a day for 6 weeks. Intervention 2: Control group: Placebo tablet 250 mg orally twice a day for
Sponsors
Boushehr University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Having a chief complaint of tinnitus for more than 3 months Presence of non-pulsatile tinnitus Ages 18-70 years
Exclusion criteria
Exclusion criteria: Presence of pulsating tinnitus Presence of Meniere's disease Vestibular nerve Otosclerosis Patients who use hearing aids. Pregnancy Mental illnesses that require treatment In case of intolerance to the minimum dose of sodium valproate or a history of severe allergy to the said drug. Treatment with anticonvulsant drugs Patients with severe heart disease such as IHD and CHF
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Healing tinnitus. Timepoint: First day and 6 weeks after intervention. Method of measurement: In terms of tinnitus severity, THI and VAS questionnaires, as well as audiometry tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMeysam Abasi
Bandare-abbas University of Medical Sciences
Outcome results
None listed